Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000605343 | SCV000712142 | uncertain significance | not specified | 2016-06-02 | criteria provided, single submitter | clinical testing | The p.Gly1849Arg variant in LOXHD1 has not been previously reported in individua ls with hearing loss. This variant has been identified in 1/7912 South Asian chr omosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.o rg; dbSNP rs780560784); however, its frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation analyses sugges t that this variant may impact the protein, though this information is not predi ctive enough to determine pathogenicity. In summary, the clinical significance o f the p.Gly1849Arg variant is uncertain. |
3billion | RCV001275163 | SCV002058798 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 77 | 2022-01-03 | criteria provided, single submitter | clinical testing | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000013, PM2_M). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.872, 3CNET: 0.919, PP3_P). Therefore, this variant is classified as uncertain significance according to the recommendation of ACMG/AMP guideline. |
Centre for Clinical Genetics and Genomic Diagnostics, |
RCV004721472 | SCV005328483 | pathogenic | not provided | 2024-08-19 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001275163 | SCV001460008 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 77 | 2020-09-16 | no assertion criteria provided | clinical testing |